Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.05 trillion and total revenue of $110.19 billion.
Market Cap
1.05T
Revenue
110.19B
Profits
-42.1B
PE Ratio
n/a
Profit Margin
-38.21%
Dividend Yield
0.05%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.33B | -0.88% | 2,200,299 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.48B | -0.62% | 1,359,054 | 14.34B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.40B | 0.34% | 2,050,658 | 3.71B |
| 4 | ARGX | argenx SE | 41.09B | -3.01% | 397,175 | 4.24B |
| 5 | ONC | BeOne Medicines AG | 30.52B | -2.63% | 226,251 | 5.34B |
| 6 | INSM | Insmed Incorporated | 29.32B | -5.56% | 4,561,334 | 606.42M |
| 7 | BNTX | BioNTech SE | 22.44B | -0.04% | 1,573,353 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.29B | -1.89% | 15,475,545 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.82B | -0.36% | 20,859,011 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.43B | -0.37% | 8,390,730 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.98B | -3.54% | 3,380,492 | - |
| 12 | INCY | Incyte Corporation | 18.07B | -2.33% | 4,387,385 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.55B | -2.45% | 2,195,908 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.62B | -1.07% | 432,802 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.29B | -2.18% | 2,905,974 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.03B | -1.34% | 3,872,618 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.73B | -0.46% | 2,919,219 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.12B | -0.65% | 1,077,328 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.72B | 0.02% | 6,698,386 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -1.64% | 4,352,866 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.12B | -2.88% | 573,976 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.37B | -2.19% | 1,379,997 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 8.71B | -3.97% | 31,631,003 | 113.29M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.31B | 0.27% | 965,887 | 7.46M |
| 25 | TECH | Bio-Techne Corporation | 8.05B | -0.21% | 3,098,056 | 1.22B |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.03B | -1.23% | 849,313 | 638.50M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.89B | -1.11% | 6,252,648 | 1.09B |
| 28 | PCVX | Vaxcyte, Inc. | 7.88B | 1.37% | 4,081,205 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 7.60B | -1.99% | 3,212,096 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.49B | 0.25% | 3,565,580 | 1.40B |
| 31 | NUVL | Nuvalent, Inc. | 7.45B | -2.36% | 951,598 | - |
| 32 | KRYS | Krystal Biotech, Inc. | 7.36B | -2.45% | 839,568 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.71B | 0.38% | 3,174,120 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.36B | -2.09% | 1,197,728 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.31B | -2.76% | 2,029,206 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.08B | -2.92% | 139,453 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.97B | -3.17% | 3,232,248 | 189.76M |
| 38 | CGON | CG Oncology, Inc. | 5.50B | -1.18% | 3,213,817 | 4.04M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.42B | -3.55% | 5,464,801 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.41B | -2.65% | 2,016,718 | 1.73B |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | -2.44% | 2,231,610 | 521.31M |
| 42 | XENE | Xenon Pharmaceuticals Inc. | 5.24B | -0.42% | 1,846,461 | 7.50M |
| 43 | CAI | Caris Life Sciences, Inc. | 5.20B | -2.13% | 8,271,148 | 812.03M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.13B | -1.89% | 3,288,101 | - |
| 45 | CELC | Celcuity Inc. | 4.91B | -6.15% | 1,862,616 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.80B | -0.96% | 5,156,326 | 616.29M |
| 47 | IMVT | Immunovant, Inc. | 4.68B | -2.83% | 3,884,649 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.59B | -3.59% | 2,846,548 | - |
| 49 | ERAS | Erasca, Inc. | 4.54B | -4.33% | 17,307,903 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.35% | 10,968,532 | 634.21M |
| 51 | CRSP | CRISPR Therapeutics AG | 4.44B | -1.51% | 2,561,147 | 3.51M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.36B | -1.26% | 4,863,348 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.08B | -2.70% | 468,242 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.74B | -4.69% | 3,522,943 | - |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.72B | -0.70% | 1,315,938 | 7.70M |
| 56 | CORT | Corcept Therapeutics Incorporated | 3.68B | 1.64% | 3,204,820 | 761.41M |
| 57 | CNTA | Centessa Pharmaceuticals plc | 3.64B | -4.53% | 573,390 | 15.00M |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 3.54B | 0.10% | 3,343,683 | 1.07B |
| 59 | DNTH | Dianthus Therapeutics, Inc. | 3.46B | -2.80% | 2,415,772 | 2.04M |
| 60 | GPCR | Structure Therapeutics Inc. | 3.44B | -3.71% | 908,665 | - |
| 61 | ADMA | ADMA Biologics, Inc. | 3.41B | -4.66% | 10,048,719 | 510.17M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | -4.99% | 909,346 | 22.50M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.24B | -2.51% | 1,410,491 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.22B | -2.57% | 1,088,687 | 1.03B |
| 65 | DNLI | Denali Therapeutics Inc. | 3.20B | 2.13% | 3,892,013 | - |
| 66 | ALMS | Alumis Inc. | 3.19B | -1.26% | 4,030,415 | 24.05M |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 3.12B | -3.29% | 1,004,060 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 2.96B | 2.10% | 374,130 | 803.79M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.90B | -1.35% | 5,064,517 | - |
| 70 | VERA | Vera Therapeutics, Inc. | 2.89B | -2.03% | 3,986,147 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | 0.46% | 2,400,449 | 218.71M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.78B | 2.06% | 3,189,125 | 588.99M |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.77B | 0.52% | 7,616,187 | 62.38M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.76B | -3.09% | 4,960,524 | 70.85M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.75B | -3.06% | 4,095,599 | 376.07M |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | -3.36% | 578,643 | 451.36M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.71B | -3.52% | 4,158,040 | 247.00M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.51B | -2.15% | 3,101,688 | 139.74M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.48B | -3.17% | 2,584,920 | 490.73M |
| 80 | MAZE | Maze Therapeutics, Inc. | 2.31B | -2.83% | 1,329,430 | 2.50M |
| 81 | IMNM | Immunome, Inc. | 2.26B | -3.94% | 5,730,408 | 6.94M |
| 82 | IRON | Disc Medicine, Inc. | 2.22B | -1.69% | 2,170,013 | - |
| 83 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.23% | 6,907,698 | 158.18M |
| 84 | WVE | Wave Life Sciences Ltd. | 2.21B | -2.97% | 5,819,560 | 42.73M |
| 85 | APLS | Apellis Pharmaceuticals, Inc. | 2.20B | -4.23% | 5,601,439 | 1.00B |
| 86 | MANE | Veradermics, Incorporated | 2.20B | 3.48% | 1,324,080 | - |
| 87 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | 0.96% | 2,932,420 | 172.35M |
| 88 | GLPG | Galapagos NV | 2.11B | -1.60% | 134,842 | 1.31B |
| 89 | ADPT | Adaptive Biotechnologies Corporation | 2.09B | 0.59% | 2,359,860 | 276.98M |
| 90 | NKTR | Nektar Therapeutics | 2.07B | -3.50% | 837,230 | 55.23M |
| 91 | CLDX | Celldex Therapeutics, Inc. | 2.06B | 2.90% | 3,242,793 | 1.55M |
| 92 | ZLAB | Zai Lab Limited | 2.00B | -2.79% | 1,622,482 | 460.16M |
| 93 | TYRA | Tyra Biosciences, Inc. | 2.00B | -2.70% | 2,124,381 | - |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 1.98B | 3.39% | 2,894,954 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 1.98B | 0.96% | 2,012,422 | 184.42M |
| 96 | ORKA | Oruka Therapeutics, Inc. | 1.93B | 0.23% | 1,257,395 | - |
| 97 | RARE | Ultragenyx Pharmaceutical Inc. | 1.92B | -2.69% | 3,795,616 | 673.00M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.86B | -0.36% | 1,259,473 | 283.06M |
| 99 | MESO | Mesoblast Limited | 1.85B | -2.84% | 258,986 | 65.38M |
| 100 | DFTX | Definium Therapeutics, Inc. | 1.83B | -1.39% | 2,580,696 | - |
| 101 | ANAB | AnaptysBio, Inc. | 1.79B | -3.64% | 1,464,657 | 234.60M |
| 102 | OCUL | Ocular Therapeutix, Inc. | 1.78B | -1.09% | 4,158,413 | 51.95M |
| 103 | AAPG | Ascentage Pharma Group International | 1.78B | -13.29% | 17,800 | 54.52M |
| 104 | RLAY | Relay Therapeutics, Inc. | 1.77B | -0.90% | 3,822,980 | 15.36M |
| 105 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | 0.24% | 2,864,360 | 2.20B |
| 106 | ELVN | Enliven Therapeutics, Inc. | 1.74B | -3.39% | 862,451 | - |
| 107 | ZYME | Zymeworks Inc. | 1.72B | -2.43% | 604,047 | 105.97M |
| 108 | SLNO | Soleno Therapeutics, Inc. | 1.71B | -1.16% | 1,701,311 | 190.41M |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -3.56% | 26,875,353 | 74.68M |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.67B | -6.64% | 5,760,743 | 11.13M |
| 111 | SION | Sionna Therapeutics, Inc. | 1.64B | 2.54% | 339,074 | - |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | -0.21% | 1,618,703 | 54.03M |
| 113 | INVA | Innoviva, Inc. | 1.61B | -1.77% | 2,707,111 | 411.33M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.32% | 1,027,662 | 868.45M |
| 115 | VCEL | Vericel Corporation | 1.59B | -4.06% | 1,201,797 | 276.26M |
| 116 | NVAX | Novavax, Inc. | 1.57B | -1.23% | 5,683,845 | 1.12B |
| 117 | GENB | Generate Biomedicines, Inc. | 1.56B | -0.16% | 519,552 | 31.89M |
| 118 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -4.65% | 23,495,669 | 263.50M |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.52B | -2.36% | 5,219,586 | 67.67M |
| 120 | IMCR | Immunocore Holdings plc | 1.52B | -0.43% | 278,692 | 400.02M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.48B | -3.28% | 5,442,418 | 83.98M |
| 122 | OCS | Oculis Holding AG | 1.47B | -2.01% | 281,902 | 1.51M |
| 123 | NUVB | Nuvation Bio Inc. | 1.47B | -0.94% | 7,276,290 | 62.90M |
| 124 | PHVS | Pharvaris N.V. | 1.42B | -0.57% | 162,910 | - |
| 125 | NBTX | Nanobiotix S.A. | 1.41B | -8.16% | 43,204 | 11.93M |
| 126 | MBX | MBX Biosciences, Inc. | 1.36B | 0.88% | 670,776 | - |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.36B | -0.84% | 2,296,889 | - |
| 128 | BHVN | Biohaven Ltd. | 1.34B | -0.33% | 6,125,504 | - |
| 129 | PVLA | Palvella Therapeutics, Inc. | 1.33B | -1.24% | 374,635 | - |
| 130 | ARDX | Ardelyx, Inc. | 1.30B | -3.45% | 8,465,843 | 407.32M |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.29B | -1.38% | 496,464 | - |
| 132 | ZBIO | Zenas BioPharma, Inc. | 1.28B | -4.58% | 2,323,069 | 10.00M |
| 133 | VIR | Vir Biotechnology, Inc. | 1.27B | -2.99% | 3,932,864 | 68.56M |
| 134 | ATAI | AtaiBeckley Inc. | 1.27B | -2.24% | 17,831,925 | 4.09M |
| 135 | IMTX | Immatics N.V. | 1.26B | -2.88% | 224,340 | 56.67M |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | -3.51% | 5,529,416 | 9.77M |
| 137 | GLUE | Monte Rosa Therapeutics, Inc. | 1.25B | -2.68% | 5,472,307 | 123.67M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | -5.88% | 8,304,924 | - |
| 139 | KOD | Kodiak Sciences Inc. | 1.18B | -1.85% | 2,461,312 | - |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.17B | -2.46% | 694,529 | - |
| 141 | PGEN | Precigen, Inc. | 1.16B | -1.20% | 3,163,626 | 6.31M |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 0.54% | 3,695,692 | - |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | -5.39% | 4,927,071 | - |
| 144 | EYPT | EyePoint, Inc. | 1.10B | -4.06% | 1,034,883 | 31.37M |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.09B | -5.52% | 967,325 | - |
| 146 | SEPN | Septerna, Inc. | 1.09B | -0.41% | 489,837 | 45.95M |
| 147 | TVGN | Tevogen Bio Holdings Inc. | 1.06B | -1.69% | 64,063 | - |
| 148 | PHAR | Pharming Group N.V. | 1.05B | -0.71% | 21,682 | 376.13M |
| 149 | ABCL | AbCellera Biologics Inc. | 1.03B | -3.68% | 2,457,028 | 75.13M |
| 150 | SVRA | Savara Inc. | 1.02B | -3.88% | 9,317,223 | - |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.01B | -2.02% | 1,190,899 | - |
| 152 | QURE | uniQure N.V. | 1.01B | 5.44% | 5,755,218 | 16.10M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 973.32M | -3.67% | 1,300,424 | - |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 938.03M | -2.51% | 2,167,973 | 291.85M |
| 155 | GERN | Geron Corporation | 935.20M | -5.81% | 39,134,788 | 183.88M |
| 156 | AKTS | Aktis Oncology, Inc. | 929.64M | -1.56% | 3,905,197 | 5.56M |
| 157 | CMPX | Compass Therapeutics, Inc. | 927.45M | -4.45% | 5,577,494 | 850.00K |
| 158 | VALN | Valneva SE | 894.82M | -1.71% | 3,395 | 205.07M |
| 159 | FTRE | Fortrea Holdings Inc. | 891.06M | -2.66% | 2,575,125 | 2.72B |
| 160 | INBX | Inhibrx Biosciences, Inc. | 889.86M | -6.09% | 680,546 | 1.30M |
| 161 | XNCR | Xencor, Inc. | 889.60M | 0.08% | 2,315,228 | 125.58M |
| 162 | PHAT | Phathom Pharmaceuticals, Inc. | 883.33M | 0.54% | 2,623,791 | 175.11M |
| 163 | GHRS | GH Research PLC | 866.55M | -5.67% | 240,030 | - |
| 164 | SGP | SpyGlass Pharma, Inc. | 866.25M | 1.13% | 728,465 | - |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 859.29M | 3.47% | 1,382,556 | 1.43M |
| 166 | URGN | UroGen Pharma Ltd. | 857.78M | -5.22% | 975,322 | 109.79M |
| 167 | JANX | Janux Therapeutics, Inc. | 855.29M | -0.71% | 5,033,092 | 10.00M |
| 168 | SLS | SELLAS Life Sciences Group, Inc. | 854.81M | -8.46% | 29,521,654 | - |
| 169 | EVMN | Evommune, Inc. | 840.31M | -0.98% | 1,500,429 | 13.00M |
| 170 | SANA | Sana Biotechnology, Inc. | 829.96M | -1.89% | 9,276,590 | - |
| 171 | ANL | Adlai Nortye Ltd. | 819.19M | 0.54% | 251,921 | -1.35M |
| 172 | ABUS | Arbutus Biopharma Corporation | 815.45M | -2.97% | 3,729,555 | 14.61M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 811.26M | -0.97% | 3,314,231 | 84.28M |
| 174 | IVA | Inventiva S.A. | 804.29M | -4.30% | 351,366 | 19.93M |
| 175 | OMER | Omeros Corporation | 779.91M | -1.08% | 1,318,498 | - |
| 176 | CGEM | Cullinan Therapeutics, Inc. | 771.10M | -2.60% | 1,713,163 | - |
| 177 | MPLT | MapLight Therapeutics, Inc. | 766.34M | 0.40% | 714,590 | - |
| 178 | MNKD | MannKind Corporation | 761.01M | -1.98% | 19,093,665 | 348.97M |
| 179 | CTMX | CytomX Therapeutics, Inc. | 757.33M | -6.90% | 8,905,277 | 76.20M |
| 180 | KURA | Kura Oncology, Inc. | 729.60M | -2.02% | 2,695,379 | 67.48M |
| 181 | TBPH | Theravance Biopharma, Inc. | 726.14M | 2.28% | 1,486,922 | 107.46M |
| 182 | DRUG | Bright Minds Biosciences Inc. | 713.65M | -0.91% | 275,258 | - |
| 183 | ARVN | Arvinas, Inc. | 699.73M | -2.06% | 2,200,618 | 262.60M |
| 184 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 694.68M | -4.09% | 193,340 | - |
| 185 | SLDB | Solid Biosciences Inc. | 691.69M | -1.26% | 1,457,388 | - |
| 186 | JBIO | Jade Biosciences, Inc. | 690.43M | -0.57% | 2,603,538 | - |
| 187 | ANRO | Alto Neuroscience, Inc. | 685.87M | -2.59% | 423,583 | - |
| 188 | OCGN | Ocugen, Inc. | 668.91M | -8.93% | 25,069,903 | 4.41M |
| 189 | LXRX | Lexicon Pharmaceuticals, Inc. | 660.94M | -3.70% | 6,680,625 | 49.80M |
| 190 | GYRE | Gyre Therapeutics, Inc. | 651.60M | -1.18% | 224,787 | 116.59M |
| 191 | EIKN | Eikon Therapeutics, Inc. | 638.09M | 7.65% | 1,630,175 | - |
| 192 | RLMD | Relmada Therapeutics, Inc. | 636.68M | -2.88% | 1,567,844 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 635.84M | 0.49% | 394,348 | - |
| 194 | PRME | Prime Medicine, Inc. | 635.54M | -4.35% | 5,987,807 | 4.63M |
| 195 | DRTS | Alpha Tau Medical Ltd. | 622.23M | -3.42% | 179,660 | - |
| 196 | MDXG | MiMedx Group, Inc. | 612.09M | -1.20% | 4,779,107 | 418.63M |
| 197 | ANNX | Annexon, Inc. | 611.32M | -6.92% | 10,014,470 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 595.29M | -1.92% | 777,981 | - |
| 199 | AGMB | AgomAb Therapeutics NV | 594.10M | -4.02% | 179,546 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 579.53M | -2.04% | 443,359 | 27.42M |
| 201 | REPL | Replimune Group, Inc. | 576.36M | 1.31% | 2,446,971 | - |
| 202 | TECX | Tectonic Therapeutic, Inc. | 561.05M | -3.08% | 290,715 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 541.91M | -1.81% | 833,946 | 106.47M |
| 204 | DBVT | DBV Technologies S.A. | 522.54M | -1.85% | 294,496 | 5.50M |
| 205 | ZURA | Zura Bio Limited | 521.84M | -10.13% | 1,203,909 | - |
| 206 | ALLO | Allogene Therapeutics, Inc. | 504.62M | -6.76% | 20,748,046 | 22.00K |
| 207 | CRMD | CorMedix Inc. | 494.06M | -0.79% | 2,012,929 | 311.71M |
| 208 | ADCT | ADC Therapeutics SA | 490.39M | -4.46% | 2,421,483 | 81.36M |
| 209 | VSTM | Verastem, Inc. | 485.73M | -4.98% | 3,828,392 | 30.91M |
| 210 | ENGN | enGene Holdings Inc. | 482.99M | -0.14% | 193,056 | - |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 479.56M | -0.54% | 463,539 | 294.28M |
| 212 | PRTA | Prothena Corporation plc | 471.04M | 2.46% | 1,401,557 | 9.68M |
| 213 | UPB | Upstream Bio, Inc. | 468.51M | 3.46% | 3,024,934 | 2.80M |
| 214 | LRMR | Larimar Therapeutics, Inc. | 466.43M | 0.45% | 2,844,504 | - |
| 215 | CTNM | Contineum Therapeutics, Inc. | 455.87M | 0.83% | 1,404,567 | - |
| 216 | ASMB | Assembly Biosciences, Inc. | 451.45M | 3.45% | 83,925 | 72.30M |
| 217 | AVIR | Atea Pharmaceuticals, Inc. | 450.94M | -5.67% | 950,086 | - |
| 218 | FULC | Fulcrum Therapeutics, Inc. | 450.88M | -3.84% | 4,434,940 | 80.00M |
| 219 | RCKT | Rocket Pharmaceuticals, Inc. | 449.48M | -5.69% | 11,125,547 | - |
| 220 | LYEL | Lyell Immunopharma, Inc. | 445.63M | -7.94% | 108,913 | 36.00K |
| 221 | STTK | Shattuck Labs, Inc. | 445.13M | 1.97% | 733,499 | 1.00M |
| 222 | ABSI | Absci Corporation | 445.10M | -3.90% | 8,377,261 | 2.82M |
| 223 | ACRS | Aclaris Therapeutics, Inc. | 445.00M | -1.34% | 2,196,008 | 7.83M |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 439.55M | -4.12% | 1,373,451 | 85.21M |
| 225 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.91M | -6.58% | 258,103 | - |
| 226 | MRVI | Maravai LifeSciences Holdings, Inc. | 436.22M | -1.65% | 2,831,246 | 185.74M |
| 227 | IPSC | Century Therapeutics, Inc. | 434.93M | -2.81% | 4,987,750 | 109.16M |
| 228 | ALT | Altimmune, Inc. | 434.43M | -2.34% | 12,525,440 | 41.00K |
| 229 | TRDA | Entrada Therapeutics, Inc. | 433.00M | -5.59% | 414,705 | 25.42M |
| 230 | VNDA | Vanda Pharmaceuticals Inc. | 420.85M | -16.92% | 11,684,158 | 216.11M |
| 231 | NMRA | Neumora Therapeutics, Inc. | 419.39M | -2.33% | 625,006 | - |
| 232 | RGNX | REGENXBIO Inc. | 418.07M | -3.11% | 2,687,308 | 170.44M |
| 233 | AURA | Aura Biosciences, Inc. | 415.95M | -0.46% | 438,199 | - |
| 234 | LXEO | Lexeo Therapeutics, Inc. | 412.38M | -2.42% | 1,982,297 | - |
| 235 | DNA | Ginkgo Bioworks Holdings, Inc. | 395.38M | -2.89% | 1,490,756 | 170.16M |
| 236 | IVVD | Invivyd, Inc. | 389.98M | -4.83% | 6,697,442 | 53.43M |
| 237 | XFOR | X4 Pharmaceuticals, Inc. | 389.14M | 2.64% | 684,979 | 35.11M |
| 238 | YDES | YD Bio Limited | 383.95M | 0.74% | 55,344 | 510.36K |
| 239 | NAUT | Nautilus Biotechnology, Inc. | 382.70M | 10.18% | 500,274 | - |
| 240 | PRTC | PureTech Health plc | 381.76M | -2.22% | 1,603 | 6.39M |
| 241 | BNTC | Benitec Biopharma Inc. | 377.21M | -4.52% | 716,285 | - |
| 242 | AVXL | Anavex Life Sciences Corp. | 376.25M | -3.33% | 2,767,795 | - |
| 243 | NAGE | Niagen Bioscience, Inc. | 373.18M | -1.69% | 1,236,844 | 129.42M |
| 244 | MNPR | Monopar Therapeutics Inc. | 368.95M | -5.90% | 263,652 | - |
| 245 | AUTL | Autolus Therapeutics plc | 364.62M | -4.20% | 1,660,830 | 51.13M |
| 246 | CADL | Candel Therapeutics, Inc. | 364.04M | 1.22% | 1,652,363 | - |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 363.03M | -3.77% | 199,671 | 66.98M |
| 248 | LCTX | Lineage Cell Therapeutics, Inc. | 361.18M | -6.45% | 1,447,900 | 14.56M |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 352.04M | -3.70% | 285,624 | - |
| 250 | KYTX | Kyverna Therapeutics, Inc. | 347.74M | -7.03% | 1,571,632 | - |
| 251 | OVID | Ovid Therapeutics Inc. | 345.51M | 13.91% | 10,114,724 | 6.61M |
| 252 | XOMA | XOMA Royalty Corporation | 341.81M | -0.17% | 134,999 | 52.15M |
| 253 | GLSI | Greenwich LifeSciences, Inc. | 333.89M | -6.88% | 141,435 | - |
| 254 | LENZ | LENZ Therapeutics, Inc. | 327.92M | -8.79% | 1,527,147 | 17.50M |
| 255 | NERV | Minerva Neurosciences, Inc. | 326.29M | -6.57% | 2,259,192 | - |
| 256 | PEPG | PepGen Inc. | 324.84M | -1.47% | 653,775 | - |
| 257 | IMRX | Immuneering Corporation | 324.56M | 3.29% | 7,274,505 | - |
| 258 | PALI | Palisade Bio, Inc. | 313.52M | -5.03% | 2,954,024 | - |
| 259 | IRD | Opus Genetics, Inc. | 312.34M | -4.15% | 846,822 | 14.20M |
| 260 | PBYI | Puma Biotechnology, Inc. | 311.36M | -0.49% | 340,266 | 228.37M |
| 261 | IMMX | Immix Biopharma, Inc. | 305.89M | -5.89% | 2,006,968 | - |
| 262 | ARMP | Armata Pharmaceuticals, Inc. | 304.81M | 1.21% | 57,404 | 5.05M |
| 263 | BCYC | Bicycle Therapeutics plc | 303.23M | -4.40% | 975,895 | 72.59M |
| 264 | CBIO | Crescent Biopharma, Inc. | 300.37M | 2.64% | 184,574 | 10.84M |
| 265 | NBP | NovaBridge Biosciences | 295.15M | -4.83% | 502,613 | - |
| 266 | NGNE | Neurogene Inc. | 295.08M | -0.73% | 300,286 | 925.00K |
| 267 | FBRX | Forte Biosciences, Inc. | 294.38M | -4.51% | 205,739 | - |
| 268 | FHTX | Foghorn Therapeutics Inc. | 293.50M | 2.25% | 390,721 | 30.91M |
| 269 | CLYM | Climb Bio, Inc. | 291.86M | -12.46% | 564,857 | - |
| 270 | SLN | Silence Therapeutics plc | 291.43M | -3.29% | 255,001 | 559.00K |
| 271 | ACIU | AC Immune SA | 290.05M | -3.39% | 232,833 | 4.51M |
| 272 | ALXO | ALX Oncology Holdings Inc. | 286.91M | -0.46% | 1,268,403 | - |
| 273 | CABA | Cabaletta Bio, Inc. | 283.02M | -3.29% | 1,738,550 | - |
| 274 | TARA | Protara Therapeutics, Inc. | 281.78M | -1.70% | 3,216,275 | - |
| 275 | PROK | ProKidney Corp. | 273.95M | -1.03% | 689,791 | 893.00K |
| 276 | OBIO | Orchestra BioMed Holdings, Inc. | 271.54M | - | 474,837 | 33.48M |
| 277 | CNTX | Context Therapeutics Inc. | 264.61M | -3.68% | 636,188 | - |
| 278 | CCCC | C4 Therapeutics, Inc. | 263.46M | 3.45% | 3,310,660 | 35.95M |
| 279 | PLYX | Polaryx Therapeutics, Inc. | 262.28M | -1.95% | 1,160,121 | - |
| 280 | CAMP | Camp4 Therapeutics Corporation | 259.60M | -3.10% | 372,843 | 3.50M |
| 281 | ABEO | Abeona Therapeutics Inc. | 253.87M | -1.98% | 1,693,370 | 5.82M |
| 282 | OABI | OmniAb, Inc. | 253.37M | -4.89% | 899,529 | 18.67M |
| 283 | TENX | Tenax Therapeutics, Inc. | 245.93M | -4.09% | 227,799 | - |
| 284 | CLLS | Cellectis S.A. | 245.04M | -4.02% | 103,093 | 79.59M |
| 285 | AVTX | Avalo Therapeutics, Inc. | 243.36M | -5.63% | 477,504 | 192.00K |
| 286 | RZLT | Rezolute, Inc. | 238.29M | 0.81% | 8,710,388 | - |
| 287 | HELP | Cybin Inc. | 231.17M | -3.95% | 474,771 | - |
| 288 | VYGR | Voyager Therapeutics, Inc. | 229.16M | 2.81% | 580,607 | 40.37M |
| 289 | EDIT | Editas Medicine, Inc. | 229.02M | -0.43% | 1,778,641 | 40.52M |
| 290 | CHRS | Coherus Oncology, Inc. | 227.83M | -5.59% | 2,667,377 | 42.17M |
| 291 | ALEC | Alector, Inc. | 226.24M | -0.49% | 1,924,891 | 21.05M |
| 292 | ELDN | Eledon Pharmaceuticals, Inc. | 218.45M | 1.05% | 4,029,359 | - |
| 293 | NVCT | Nuvectis Pharma, Inc. | 218.03M | 1.86% | 113,027 | - |
| 294 | MDWD | MediWound Ltd. | 217.68M | -0.06% | 80,964 | 16.96M |
| 295 | KROS | Keros Therapeutics, Inc. | 216.10M | -1.44% | 2,268,319 | 244.06M |
| 296 | SRZN | Surrozen, Inc. | 215.57M | -5.56% | 66,317 | 3.60M |
| 297 | ACHV | Achieve Life Sciences, Inc. | 212.94M | -2.20% | 309,829 | - |
| 298 | FENC | Fennec Pharmaceuticals Inc. | 205.82M | -4.31% | 574,195 | 38.79M |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 203.31M | -10.70% | 16,875 | 19.39M |
| 300 | TNXP | Tonix Pharmaceuticals Holding Corp. | 201.08M | -4.88% | 1,042,727 | 13.11M |
| 301 | ELTX | Elicio Therapeutics, Inc. | 199.60M | -9.43% | 198,785 | - |
| 302 | CGEN | Compugen Ltd. | 197.62M | -0.95% | 194,152 | 72.76M |
| 303 | SABS | SAB Biotherapeutics, Inc. | 191.07M | -0.79% | 1,327,795 | 114.70K |
| 304 | ZNTL | Zentalis Pharmaceuticals, Inc. | 189.30M | 2.34% | 529,025 | 26.87M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 188.44M | -1.34% | 752,061 | 82.03M |
| 306 | PRLD | Prelude Therapeutics Incorporated | 188.38M | -6.27% | 337,807 | 12.14M |
| 307 | MGNX | MacroGenics, Inc. | 181.77M | -1.38% | 644,154 | 149.50M |
| 308 | CRBU | Caribou Biosciences, Inc. | 180.71M | -5.08% | 958,373 | 11.16M |
| 309 | GALT | Galectin Therapeutics Inc. | 177.30M | -1.79% | 147,638 | - |
| 310 | STRO | Sutro Biopharma, Inc. | 176.06M | -2.08% | 598,104 | 105.65M |
| 311 | RNAC | Cartesian Therapeutics, Inc. | 172.57M | -0.91% | 104,775 | 2.80M |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 172.10M | -4.04% | 1,539,550 | 52.74M |
| 313 | CBUS | Cibus, Inc. | 171.61M | -6.77% | 1,044,017 | 3.79M |
| 314 | MOLN | Molecular Partners AG | 171.53M | -2.24% | 2,686 | 856.30K |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 171.30M | -1.63% | 470,773 | - |
| 316 | ADAG | Adagene Inc. | 171.09M | -1.63% | 141,425 | 103.20K |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 169.44M | - | 281,141 | 7.15M |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 165.88M | -8.63% | 56,791 | 59.99K |
| 319 | EVAX | Evaxion A/S | 163.05M | -2.25% | 21,415 | 7.53M |
| 320 | TNYA | Tenaya Therapeutics, Inc. | 163.01M | -6.53% | 4,148,491 | - |
| 321 | PRQR | ProQR Therapeutics N.V. | 162.26M | -3.14% | 144,698 | 19.19M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 161.73M | -8.56% | 491,113 | - |
| 323 | DTIL | Precision BioSciences, Inc. | 161.22M | -2.98% | 548,729 | 34.26M |
| 324 | PMN | ProMIS Neurosciences, Inc. | 157.83M | -3.35% | 15,179 | - |
| 325 | SGMT | Sagimet Biosciences Inc. | 157.06M | -0.21% | 369,959 | - |
| 326 | KRRO | Korro Bio, Inc. | 155.04M | -2.80% | 179,981 | 6.39M |
| 327 | CNTB | Connect Biopharma Holdings Limited | 154.29M | -2.09% | 112,541 | 762.00K |
| 328 | VXRT | Vaxart, Inc. | 153.53M | -2.62% | - | 237.26M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 152.53M | -3.80% | 141,450 | - |
| 330 | NKTX | Nkarta, Inc. | 152.00M | -1.38% | 903,142 | - |
| 331 | KLRS | Kalaris Therapeutics, Inc. | 150.41M | -3.67% | 57,900 | - |
| 332 | HRTX | Heron Therapeutics, Inc. | 146.80M | -4.74% | 2,039,472 | 154.90M |
| 333 | HUMA | Humacyte, Inc. | 146.61M | -8.34% | 31,530,000 | 1.57M |
| 334 | CDXS | Codexis, Inc. | 145.39M | -4.19% | 1,823,432 | 70.39M |
| 335 | UNCY | Unicycive Therapeutics, Inc. | 144.64M | -1.17% | 458,602 | - |
| 336 | ANTX | AN2 Therapeutics, Inc. | 143.76M | 2.30% | 267,383 | - |
| 337 | IMUX | Immunic, Inc. | 143.51M | -5.17% | 2,019,189 | - |
| 338 | AGEN | Agenus Inc. | 142.46M | -2.62% | 382,624 | 114.20M |
| 339 | VTVT | vTv Therapeutics Inc. | 141.79M | 0.08% | 30,598 | 17.00K |
| 340 | KPTI | Karyopharm Therapeutics Inc. | 139.96M | -1.29% | 1,496,158 | 146.07M |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 138.91M | -3.32% | 81,367 | 2.00M |
| 342 | MIST | Milestone Pharmaceuticals Inc. | 138.15M | -20.00% | 5,775,496 | 1.55M |
| 343 | IKT | Inhibikase Therapeutics, Inc. | 135.32M | -1.64% | 8,868,800 | 1.00 |
| 344 | SPRO | Spero Therapeutics, Inc. | 133.52M | -4.05% | 235,757 | 40.55M |
| 345 | ARTV | Artiva Biotherapeutics, Inc. | 131.49M | -3.62% | 89,401 | 251.00K |
| 346 | EQ | Equillium, Inc. | 129.70M | -0.47% | 660,970 | 4.39M |
| 347 | FATE | Fate Therapeutics, Inc. | 127.89M | 1.85% | 3,469,514 | 6.65M |
| 348 | MENS | Jyong Biotech Ltd. | 126.20M | -1.40% | 191,520 | - |
| 349 | VOR | Vor Biopharma Inc. | 125.34M | -8.58% | 4,553,322 | - |
| 350 | ACOG | Alpha Cognition Inc. | 124.15M | -2.23% | 10,704 | 7.43M |
| 351 | CRDF | Cardiff Oncology, Inc. | 123.06M | -1.10% | 429,332 | 593.00K |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 120.88M | -1.86% | 725,641 | 70.00M |
| 353 | SGMO | Sangamo Therapeutics, Inc. | 111.62M | -2.73% | 7,676,200 | 32.88M |
| 354 | RANI | Rani Therapeutics Holdings, Inc. | 110.22M | -1.74% | 906,675 | 1.20M |
| 355 | IPHA | Innate Pharma S.A. | 109.65M | -7.87% | 44,969 | 14.84M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 109.17M | -4.24% | 993,817 | 65.34K |
| 357 | ALDX | Aldeyra Therapeutics, Inc. | 108.93M | -1.09% | 10,644,006 | - |
| 358 | GNLX | Genelux Corporation | 107.53M | -5.51% | 504,617 | 8.00K |
| 359 | ONCY | Oncolytics Biotech Inc. | 102.23M | -2.95% | 540,753 | - |
| 360 | TTRX | Turn Therapeutics Inc. | 101.29M | 0.29% | 13,687 | - |
| 361 | DWTX | Dogwood Therapeutics, Inc. | 100.20M | 10.50% | 337,080 | - |
| 362 | HURA | TuHURA Biosciences, Inc. | 99.44M | 8.38% | 2,141,983 | - |
| 363 | GOSS | Gossamer Bio, Inc. | 99.14M | -6.55% | 29,583,915 | 48.47M |
| 364 | COYA | Coya Therapeutics, Inc. | 98.75M | -1.41% | 141,971 | 7.95M |
| 365 | QTTB | Q32 Bio Inc. | 97.72M | 0.15% | 384,306 | 53.74M |
| 366 | SEER | Seer, Inc. | 94.79M | -2.61% | 263,199 | 16.58M |
| 367 | CGTX | Cognition Therapeutics, Inc. | 94.45M | -0.93% | 636,345 | - |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 93.62M | -6.03% | 401,476 | 35.58M |
| 369 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 93.48M | -4.01% | 1,978,948 | - |
| 370 | FBIO | Fortress Biotech, Inc. | 92.80M | -4.78% | 325,834 | 62.30M |
| 371 | PYXS | Pyxis Oncology, Inc. | 91.53M | -4.55% | 188,118 | 2.82M |
| 372 | ANIX | Anixa Biosciences, Inc. | 88.85M | -4.33% | 107,560 | - |
| 373 | AARD | Aardvark Therapeutics, Inc. | 88.62M | -16.94% | 437,653 | - |
| 374 | CING | Cingulate Inc. | 85.82M | -1.73% | 1,184,015 | - |
| 375 | NRXS | NeurAxis, Inc. | 85.25M | 6.42% | 609,379 | 3.57M |
| 376 | VANI | Vivani Medical, Inc. | 84.62M | 0.87% | 742,196 | - |
| 377 | IBO | Impact BioMedical Inc. | 84.10M | 68.47% | 7,372,690 | 32.00K |
| 378 | KZIA | Kazia Therapeutics Limited | 81.50M | -5.44% | 61,163 | 1.35M |
| 379 | MCRB | Seres Therapeutics, Inc. | 81.48M | -6.39% | 84,719 | 789.00K |
| 380 | CSBR | Champions Oncology, Inc. | 81.38M | -5.48% | 4,247 | 57.95M |
| 381 | BMEA | Biomea Fusion, Inc. | 80.60M | 4.59% | 984,897 | - |
| 382 | SPRB | Spruce Biosciences, Inc. | 80.13M | -1.10% | 33,251 | 697.00K |
| 383 | PLRX | Pliant Therapeutics, Inc. | 79.87M | -3.01% | 443,330 | - |
| 384 | ATYR | aTyr Pharma, Inc. | 79.25M | -2.33% | 876,847 | 190.00K |
| 385 | PMVP | PMV Pharmaceuticals, Inc. | 78.39M | -2.00% | 283,929 | - |
| 386 | MNOV | MediciNova, Inc. | 76.79M | 12.23% | 400,468 | 409.66K |
| 387 | PYPD | PolyPid Ltd. | 75.73M | -4.81% | 44,360 | - |
| 388 | ANVS | Annovis Bio, Inc. | 73.72M | -2.62% | 746,179 | - |
| 389 | XBIT | XBiotech Inc. | 72.87M | 1.70% | 90,248 | - |
| 390 | IBIO | iBio, Inc. | 72.20M | -0.48% | 1,204,296 | 300.00K |
| 391 | GANX | Gain Therapeutics, Inc. | 70.39M | 2.63% | 760,446 | - |
| 392 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.32M | - | 94,428 | 1.36M |
| 393 | GRCE | Grace Therapeutics, Inc. | 68.40M | 0.91% | 490,091 | - |
| 394 | IFRX | InflaRx N.V. | 67.96M | 3.34% | 1,030,350 | 34.44K |
| 395 | PTHS | Pelthos Therapeutics Inc. | 67.11M | -9.71% | 7,215 | 16.80M |
| 396 | ACET | Adicet Bio, Inc. | 66.41M | -2.12% | 96,226 | - |
| 397 | BYSI | BeyondSpring Inc. | 64.53M | 2.56% | 22,032 | 1.88M |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 64.32M | -2.35% | 451,303 | - |
| 399 | EDSA | Edesa Biotech, Inc. | 61.36M | 1.66% | 2,470,297 | - |
| 400 | IMA | ImageneBio, Inc. | 60.62M | - | 55,405 | 800.00K |
| 401 | GUTS | Fractyl Health, Inc. | 60.48M | 1.08% | 1,667,687 | 3.00K |
| 402 | EXOZ | eXoZymes, Inc. | 60.47M | -2.30% | 7,795 | -700.00 |
| 403 | ATHE | Alterity Therapeutics Limited | 59.63M | -4.64% | 10,522 | 4.43M |
| 404 | TCRX | TScan Therapeutics, Inc. | 59.18M | - | 586,291 | 10.33M |
| 405 | IMMP | Immutep Limited | 57.94M | -4.34% | 1,439,280 | 5.28M |
| 406 | TIL | Instil Bio, Inc. | 57.78M | 0.47% | 27,074 | - |
| 407 | HYFT | MindWalk Holdings Corp. | 57.61M | -4.92% | 110,098 | 20.70M |
| 408 | OKUR | OnKure Therapeutics, Inc. | 57.29M | -4.34% | 388,686 | - |
| 409 | RADX | Radiopharm Theranostics Limited | 56.65M | 1.59% | 43,203 | 10.86M |
| 410 | ICCC | ImmuCell Corporation | 54.91M | -1.30% | 41,198 | 27.64M |
| 411 | ACTU | Actuate Therapeutics, Inc. | 54.62M | -6.00% | 123,653 | - |
| 412 | MREO | Mereo BioPharma Group plc | 54.59M | -5.18% | 1,787,816 | 500.00K |
| 413 | OSTX | OS Therapies Incorporated | 54.23M | 2.67% | 516,079 | - |
| 414 | MAIA | MAIA Biotechnology, Inc. | 54.07M | -2.67% | 646,430 | - |
| 415 | MGX | Metagenomi Therapeutics, Inc. | 53.42M | -3.40% | 182,272 | 25.21M |
| 416 | LPCN | Lipocine Inc. | 52.19M | -2.19% | 79,353 | 1.98M |
| 417 | NRXP | NRx Pharmaceuticals, Inc. | 51.98M | 0.54% | 807,923 | 242.00K |
| 418 | ENTX | Entera Bio Ltd. | 50.90M | -6.72% | 152,190 | 124.00K |
| 419 | DCOY | Decoy Therapeutics Inc. | 47.66M | -6.51% | 16,890 | - |
| 420 | KZR | Kezar Life Sciences, Inc. | 47.09M | -4.03% | 48,401 | - |
| 421 | RLYB | Rallybio Corporation | 46.92M | -2.42% | 145,810 | 858.00K |
| 422 | ATOS | Atossa Therapeutics, Inc. | 45.90M | 3.90% | 159,461 | - |
| 423 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | - | 97,340 | - |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.25M | -0.20% | 88,390 | 170.00K |
| 425 | NTRB | Nutriband Inc. | 44.41M | -6.58% | 45,524 | 2.28M |
| 426 | GOVX | GeoVax Labs, Inc. | 44.19M | 2.80% | 147,720 | 3.35M |
| 427 | INKT | MiNK Therapeutics, Inc. | 44.17M | -3.39% | 28,254 | - |
| 428 | LITS | Lite Strategy, Inc. | 42.54M | - | 301,890 | - |
| 429 | PSTV | Plus Therapeutics, Inc. | 42.53M | 2.82% | 4,372,554 | 5.21M |
| 430 | ALGS | Aligos Therapeutics, Inc. | 42.14M | -7.22% | 58,232 | 2.19M |
| 431 | PTN | Palatin Technologies, Inc. | 41.63M | 4.33% | 34,381 | 8.96M |
| 432 | ATRA | Atara Biotherapeutics, Inc. | 40.15M | -4.10% | 62,697 | 120.77M |
| 433 | SNSE | Sensei Biotherapeutics, Inc. | 39.82M | 3.31% | 108,189 | - |
| 434 | APLM | Apollomics, Inc. | 39.70M | -3.19% | 2,588 | 6.93M |
| 435 | ESLA | Estrella Immunopharma, Inc. | 39.28M | -5.45% | 134,233 | - |
| 436 | LONA | LeonaBio, Inc. | 39.12M | -0.10% | 284,547 | - |
| 437 | HOWL | Werewolf Therapeutics, Inc. | 38.15M | -2.97% | 207,723 | 1.14M |
| 438 | CRVO | CervoMed Inc. | 37.22M | -4.96% | 41,629 | 4.01M |
| 439 | CMMB | Chemomab Therapeutics Ltd. | 36.83M | -7.77% | 71,161 | - |
| 440 | RNXT | RenovoRx, Inc. | 36.65M | -0.99% | 276,540 | 928.00K |
| 441 | VERU | Veru Inc. | 36.43M | -0.87% | 107,499 | 16.89M |
| 442 | NXTC | NextCure, Inc. | 35.57M | -0.89% | 23,892 | - |
| 443 | CELU | Celularity Inc. | 35.18M | -3.94% | 109,671 | 40.58M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 34.63M | 1.83% | 177,574 | 90.00K |
| 445 | JSPR | Jasper Therapeutics, Inc. | 34.42M | 0.82% | 216,273 | - |
| 446 | DYAI | Dyadic International, Inc. | 34.02M | 17.75% | 356,421 | 3.34M |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 33.02M | -4.35% | 64,806 | - |
| 448 | BCTX | BriaCell Therapeutics Corp. | 32.73M | -7.52% | 191,110 | - |
| 449 | RNTX | Rein Therapeutics Inc. | 32.60M | -4.62% | 184,562 | - |
| 450 | PLUR | Pluri Inc. | 31.26M | -0.64% | 4,154 | 1.34M |
| 451 | INMB | INmune Bio Inc. | 31.10M | -4.10% | 2,503,677 | 50.00K |
| 452 | ABVC | ABVC BioPharma, Inc. | 31.04M | -5.43% | 77,636 | 797.92K |
| 453 | NBY | NovaBay Pharmaceuticals, Inc. | 30.89M | -4.92% | 132,574 | 10.30M |
| 454 | TPST | Tempest Therapeutics, Inc. | 30.87M | 6.02% | 294,090 | - |
| 455 | XLO | Xilio Therapeutics, Inc. | 29.48M | - | 107,434 | 31.80M |
| 456 | OTLK | Outlook Therapeutics, Inc. | 29.16M | 4.43% | 1,785,939 | 205.70K |
| 457 | CVM | CEL-SCI Corporation | 29.10M | -6.01% | 33,133 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.85M | -2.33% | 38,932 | 6.44M |
| 459 | TLSA | Tiziana Life Sciences Ltd | 28.76M | -3.97% | 101,385 | - |
| 460 | XCUR | Exicure, Inc. | 28.36M | -6.32% | 86,846 | 500.00K |
| 461 | PDSB | PDS Biotechnology Corporation | 27.97M | -8.65% | 854,598 | - |
| 462 | SER | Serina Therapeutics, Inc. | 27.09M | 2.42% | 13,348,051 | 116.00K |
| 463 | BOLD | Boundless Bio, Inc. | 26.66M | 3.48% | 124,745 | - |
| 464 | IGC | IGC Pharma, Inc. | 26.58M | 5.22% | 766,148 | 1.11M |
| 465 | HYPD | Hyperion DeFi, Inc. | 26.48M | -10.16% | 381,528 | 345.32K |
| 466 | CUE | Cue Biopharma, Inc. | 25.96M | 0.61% | 1,015,546 | 27.47M |
| 467 | BRNS | Barinthus Biotherapeutics plc | 25.73M | - | 5,628 | 14.97M |
| 468 | NRSN | NeuroSense Therapeutics Ltd. | 25.15M | -4.53% | 165,990 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 24.85M | 4.77% | 187,172 | 14.99M |
| 470 | ENLV | Enlivex Ltd. | 24.34M | -5.56% | 240,223 | - |
| 471 | SNTI | Senti Biosciences, Inc. | 24.19M | 2.14% | 189,537 | - |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 24.13M | -5.18% | 436,859 | 789.00K |
| 473 | PASG | Passage Bio, Inc. | 23.83M | 0.68% | 97,978 | - |
| 474 | LTRN | Lantern Pharma Inc. | 23.82M | -1.39% | 44,971 | - |
| 475 | LGVN | Longeveron Inc. | 22.80M | -11.71% | 1,571,488 | 1.20M |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.34M | 1.52% | 131,455 | 3.55M |
| 477 | NNVC | NanoViricides, Inc. | 22.24M | -1.90% | 224,638 | - |
| 478 | SKYE | Skye Bioscience, Inc. | 21.66M | -0.95% | 279,299 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 20.82M | 0.86% | 281,217 | 570.00K |
| 480 | INAB | IN8bio, Inc. | 19.69M | 16.28% | 253,179 | - |
| 481 | DARE | Daré Bioscience, Inc. | 19.43M | 4.62% | 204,741 | -57.13K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 18.40M | 1.91% | 203,057 | - |
| 483 | LEXX | Lexaria Bioscience Corp. | 17.75M | -1.61% | 228,992 | 522.00K |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 17.24M | -5.15% | 393,497 | 3.94M |
| 485 | FBLG | FibroBiologics, Inc. | 17.17M | -0.74% | 972,984 | - |
| 486 | TRAW | Traws Pharma, Inc. | 17.10M | -1.83% | 58,486 | 2.85M |
| 487 | ALLR | Allarity Therapeutics, Inc. | 17.08M | -1.82% | 177,199 | - |
| 488 | ACXP | Acurx Pharmaceuticals, Inc. | 15.99M | -15.54% | 1,006,492 | - |
| 489 | LIXT | Lixte Biotechnology Holdings, Inc. | 15.63M | -5.84% | 31,264 | - |
| 490 | INTS | Intensity Therapeutics, Inc. | 15.15M | -5.53% | 48,282 | - |
| 491 | AEON | AEON Biopharma, Inc. | 14.77M | -5.31% | 64,653 | - |
| 492 | GTBP | GT Biopharma, Inc. | 14.52M | 8.16% | 1,663,659 | - |
| 493 | JUNS | Jupiter Neurosciences, Inc. | 14.29M | 10.05% | 503,338 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.20M | -5.50% | 49,153 | - |
| 495 | HOTH | Hoth Therapeutics, Inc. | 14.19M | -0.95% | 230,869 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 14.17M | 3.39% | 257,646 | - |
| 497 | CLRB | Cellectar Biosciences, Inc. | 13.74M | 1.89% | 57,474 | - |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 13.53M | -6.46% | 36,133 | - |
| 499 | PLRZ | Polyrizon Ltd. | 13.43M | 1.48% | 10,950 | - |
| 500 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.83M | -3.86% | 12,006 | - |
| 501 | BCDA | BioCardia, Inc. | 12.74M | - | 37,957 | 3.00K |
| 502 | IOBT | IO Biotech, Inc. | 12.71M | -7.05% | 998,399 | - |
| 503 | GDTC | CytoMed Therapeutics Limited | 12.69M | 4.76% | 8,199 | 573.19K |
| 504 | KAPA | Kairos Pharma, Ltd. | 12.48M | -2.52% | 216,437 | - |
| 505 | SNGX | Soligenix, Inc. | 12.10M | -1.64% | 150,412 | 2.34K |
| 506 | GNTA | Genenta Science S.p.A. | 12.07M | 0.86% | 101,901 | - |
| 507 | LNAI | Lunai Bioworks Inc. | 11.33M | 21.69% | 80,784,275 | - |
| 508 | BLRX | BioLineRx Ltd. | 11.30M | -2.18% | 9,149 | 12.74M |
| 509 | OSRH | OSR Holdings, Inc. | 11.22M | -1.44% | 449,270 | -90.52K |
| 510 | MBRX | Moleculin Biotech, Inc. | 10.99M | - | 79,682 | - |
| 511 | NCEL | NewcelX Ltd. | 10.80M | -3.27% | 12,505 | - |
| 512 | CRIS | Curis, Inc. | 9.97M | 1.89% | 279,658 | 9.44M |
| 513 | BCAB | BioAtla, Inc. | 9.91M | 7.87% | 947,890 | 11.00M |
| 514 | BOLT | Bolt Biotherapeutics, Inc. | 9.15M | 4.85% | 33,736 | 7.70M |
| 515 | PULM | Pulmatrix, Inc. | 9.09M | 15.81% | 83,001 | 3.00K |
| 516 | CALC | CalciMedica, Inc. | 9.09M | -21.68% | 393,818 | - |
| 517 | BIVI | BioVie Inc. | 9.05M | -17.81% | 168,796 | - |
| 518 | TOVX | Theriva Biologics, Inc. | 8.89M | 4.36% | 1,839,115 | - |
| 519 | IMNN | Imunon, Inc. | 8.81M | -2.71% | 50,622 | - |
| 520 | QNTM | Quantum BioPharma Ltd. | 8.69M | -5.08% | 73,065 | - |
| 521 | ITRM | Iterum Therapeutics plc | 8.51M | -5.45% | 411,669 | 390.00K |
| 522 | APRE | Aprea Therapeutics, Inc. | 8.50M | -2.79% | 89,896 | 488.24K |
| 523 | RNAZ | TransCode Therapeutics, Inc. | 8.23M | -3.54% | 14,140 | - |
| 524 | ICU | SeaStar Medical Holding Corporation | 8.04M | -1.76% | 125,657 | 881.00K |
| 525 | CLGN | CollPlant Biotechnologies Ltd. | 7.86M | 0.82% | 3,928 | 2.48M |
| 526 | PHGE | BiomX Inc. | 7.79M | -1.81% | 28,474 | - |
| 527 | ERNA | Ernexa Therapeutics Inc. | 7.75M | -1.59% | 1,834,523 | 1,000.00 |
| 528 | KPRX | Kiora Pharmaceuticals, Inc. | 7.69M | 2.96% | 54,208 | 20.00K |
| 529 | SPRC | SciSparc Ltd. | 7.51M | -0.64% | 5,683 | 1.31M |
| 530 | XBIO | Xenetic Biosciences, Inc. | 7.47M | 7.59% | 33,870 | 2.98M |
| 531 | EVGN | Evogene Ltd. | 7.38M | -0.09% | 95,525 | 3.85M |
| 532 | PMCB | PharmaCyte Biotech, Inc. | 7.37M | -2.17% | 256,550 | - |
| 533 | TCRT | Alaunos Therapeutics, Inc. | 7.19M | -2.72% | 29,170 | 6.00K |
| 534 | ALZN | Alzamend Neuro, Inc. | 6.96M | -3.17% | 123,533 | - |
| 535 | ADXN | Addex Therapeutics Ltd | 6.91M | -2.92% | 891 | 198.82K |
| 536 | GRDX | GridAI Technologies Corp. | 6.89M | -1.91% | 100,188 | - |
| 537 | NCNA | NuCana plc | 6.87M | -3.51% | 46,220 | - |
| 538 | APM | Aptorum Group Limited | 6.85M | 15.24% | 212,608 | - |
| 539 | CELZ | Creative Medical Technology Holdings, Inc. | 6.80M | -2.13% | 51,382 | 6.00K |
| 540 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.78M | -6.91% | 375,090 | 14.83K |
| 541 | CYCN | Cyclerion Therapeutics, Inc. | 6.24M | 5.30% | 61,436 | 2.86M |
| 542 | PCSA | Processa Pharmaceuticals, Inc. | 6.17M | -0.43% | 58,964 | - |
| 543 | MLEC | Moolec Science SA | 5.95M | -11.26% | 25,226 | 7.83M |
| 544 | ARTL | Artelo Biosciences, Inc. | 5.87M | 11.31% | 12,021,080 | - |
| 545 | IMRN | Immuron Limited | 5.74M | -0.85% | 6,117 | 4.99M |
| 546 | LIMN | Liminatus Pharma, Inc. | 5.74M | 5.63% | 1,632,454 | - |
| 547 | MBIO | Mustang Bio, Inc. | 5.71M | -0.27% | 79,965 | - |
| 548 | PBM | Psyence Biomedical Ltd. | 5.50M | 2.13% | 5,020 | - |
| 549 | XTLB | XTL Biopharmaceuticals Ltd. | 5.20M | -0.17% | 13,921 | 968.00K |
| 550 | SILO | Silo Pharma, Inc. | 4.79M | 10.43% | 189,087 | 72.10K |
| 551 | AKTX | Akari Therapeutics, Plc | 4.65M | -10.65% | 345,857 | - |
| 552 | BGMS | Bio Green Med Solution, Inc. | 4.61M | 2.17% | 14,219 | 81.00K |
| 553 | AZTR | Azitra, Inc. | 4.58M | 60.59% | 515,174,719 | 7.50K |
| 554 | QNCX | Quince Therapeutics, Inc. | 4.45M | -8.78% | 14,002,668 | - |
| 555 | REVB | Revelation Biosciences, Inc. | 4.43M | -0.83% | 33,347 | - |
| 556 | VIVS | VivoSim Labs, Inc. | 4.38M | -5.62% | 38,505 | 142.00K |
| 557 | GNPX | Genprex, Inc. | 4.36M | -2.08% | 252,798 | - |
| 558 | BDRX | Biodexa Pharmaceuticals Plc | 4.34M | 2.11% | 69,522 | 104.90K |
| 559 | APVO | Aptevo Therapeutics Inc. | 4.27M | 1.33% | 29,951 | - |
| 560 | MTNB | Matinas BioPharma Holdings, Inc. | 4.10M | 8.47% | 29,677 | - |
| 561 | SLXN | Silexion Therapeutics Corp | 4.06M | -15.22% | 63,486 | - |
| 562 | INDP | Indaptus Therapeutics, Inc. | 3.81M | -3.41% | 59,064 | - |
| 563 | PPBT | Purple Biotech Ltd | 3.70M | 5.04% | 9,822 | - |
| 564 | ASBP | Aspire Biopharma Holdings, Inc. | 3.61M | 9.22% | 267,936 | 1.94K |
| 565 | GRI | GRI Bio, Inc. | 3.41M | -9.58% | 50,688 | - |
| 566 | GLMD | Galmed Pharmaceuticals Ltd. | 3.29M | 2.83% | 6,801 | - |
| 567 | XRTX | XORTX Therapeutics Inc. | 3.25M | -3.66% | 49,786 | - |
| 568 | OGEN | Oragenics, Inc. | 3.23M | -0.82% | 134,423 | - |
| 569 | ADIL | Adial Pharmaceuticals, Inc. | 2.86M | 6.95% | 177,896 | - |
| 570 | ENVB | Enveric Biosciences, Inc. | 2.84M | 4.08% | 58,439 | - |
| 571 | BRTX | BioRestorative Therapies, Inc. | 2.48M | 9.25% | 4,845,366 | 383.40K |
| 572 | HCWB | HCW Biologics Inc. | 2.42M | -1.86% | 1,161,560 | 422.03K |
| 573 | SCNI | Scinai Immunotherapeutics Ltd. | 2.23M | 0.37% | 7,857 | 1.15M |
| 574 | ONCO | Onconetix, Inc. | 2.22M | 28.39% | 147,539 | 815.37K |
| 575 | BBLG | Bone Biologics Corporation | 2.08M | - | 5,527 | - |
| 576 | ENSC | Ensysce Biosciences, Inc. | 2.07M | 1.58% | 586,237 | 4.49M |
| 577 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.06M | 1.04% | 64,390 | 1.36M |
| 578 | CLDI | Calidi Biotherapeutics, Inc. | 2.03M | -5.57% | 320,207 | - |
| 579 | KALA | KALA BIO, Inc. | 1.94M | -3.70% | 2,698,712 | - |
| 580 | PPCB | Propanc Biopharma, Inc. | 1.79M | 1.45% | 811,245 | - |
| 581 | DRMA | Dermata Therapeutics, Inc. | 1.72M | 20.66% | 39,592,993 | - |
| 582 | JAGX | Jaguar Health, Inc. | 1.57M | 0.33% | 335,076 | 11.79M |
| 583 | CNSP | CNS Pharmaceuticals, Inc. | 1.42M | 5.53% | 37,211 | - |
| 584 | CMND | Clearmind Medicine Inc. | 989.89K | 0.73% | 41,454 | - |
| 585 | OKYO | OKYO Pharma Limited | 903.87K | -3.09% | 83,084 | - |
| 586 | CDT | CDT Equity Inc. | 793.03K | 0.98% | 90,284 | - |
| 587 | VRAX | Virax Biolabs Group Limited | 752.03K | -4.63% | 45,939 | 2.99K |
| 588 | ADTX | Aditxt, Inc. | 727.28K | 4.00% | 84,962 | 5.95K |
| 589 | ELAB | PMGC Holdings Inc. | 295.51K | -7.12% | 41,685 | 285.95K |
| 590 | MTVA | MetaVia Inc. | 294.82K | -4.73% | 121,459 | - |
| 591 | CANF | Can-Fite BioPharma Ltd. | 18.04K | -4.80% | 49,902 | 560.00K |